Cervical cancer is the most common gynecologic malignancy of the developing world. The oncogenic role of human papilloma virus (HPV) is well known. Attention is now focusing on the complicit genetic changes, which allow progression of these tumors. Regarding these changes, deletion of tumor suppressor genes (loss of heterozygosity [LOH]) is the preferred pathway of progression with only a subset manifesting microsatellite instability (MSI). Implicated loci include 3pl4.1-22. Several studies suggest that the mutator phenotype in cervical cancer may correlate with higher grade tumors, more advanced disease stage, and poor outcome. Unlike colorectal cancer, in which an inverse relationship has been demonstrated between microsatellite instability and loss of heterozygosity, cervical cancers expressing MSI have been found to coexpress LOH at other loci. In this study we analyzed 8-microsatellite loci including p53, DCC, APC, the MMR gene hMLHI and 2 regions of interest on chromosome 3 in a high-risk population group in which HPV infection is endemic.
1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol189:12-19, 1999
2.
2. Clarke B, Chetty R. Cell cycle aberrations in the pathogenesis of squamous cell carcinoma of the uterine cervix. Gynecol Oncol82:238-246, 2001
3.
3. Naidoo R, Chetty R. The application of microsatellites in molecular pathology. Pathol Oncol Res4:310-315, 1998
4.
4. Helland A, Borresen-Dale AL, Peltomaki P, Hektoen M, Kristensen GB, Nesland JM, de la CA, Lothe RA. Microsatellite instability in cervical and endometrial carcinomas. Int J Cancer70:499-501, 1997
5.
5. Chetty R, Pulford K, Jones M, Mathieu-Mahul D, Close P, Hussein S, Pallesen G, Ralfkiaer E, Stein H, Gatter K. SCL/Tal-I expression in T-acute lymphoblastic leukemia: An immunohistochemical and genotypic study. Hum Pathol26:994-998, 1995
6.
6. Canzian F, Salovaara R, Hemminki A, Kristo P, Chadwick RB, Aaltonen LA, de la Chapelle A. Semiautomated assessment of loss of heterozygosity and replication error in tumors. Cancer Res56:3331-3337, 1996
7.
7. Kornberg A. The golden helix. University Science Books, California, 1995
8.
8. Lazo PA. The molecular genetics of cervical carcinoma. Br J Cancer80:2008-2018, 1999
9.
9. Chung TK, Cheung TH, Wang VW, Yu MY, Wong YF. Microsatellite instability, expression of hMSH2 and hMLH1 and HPV infection in cervical cancer and their clinico-pathological association. Gynecol Obstet Invest52:98-103, 2001
10.
10. Clarke B, Chetty R. Postmodern cancer: The role of human immunodeficiency virus in uterine cervical cancer. Mol Pathol55:19-24, 2002
11.
11. Wistuba II, Syed S, Behrens C, Duong M, Milchgrub S, Muller CY, Jagirdar J, Gazdar AF. Comparison of molecular changes in cervical intraepithelial neoplasia in HIV-positive and HIV-indeterminate subjects. Gynecol Oncol74:519-526, 1999
12.
12. Butler D, Collins C, Mabruk M, Leader MB, Kay EW. Loss of FHIT expression as a potential marker of malignant progression in preinvasive squamous cervical cancer. Gynecol Oncol86:144-149, 2002
13.
13. Helland A, Kraggerud SM, Kristensen GB, Holm R, Abeler VM, Huebner K, Borresen-Dale AL, Lothe RA. Primary cervical carcinomas show 2 common regions of deletion at 3P, 1 within the FHIT gene: Evaluation of allelic imbalance at FHIT, RBI, and TP53 in relation to survival. Int J Cancer88:217-222, 2000
14.
14. Fouret PJ, Dabit D, Mergui JL, Uzan S. Loss of heterozygosity on the short arm of chromosome 3 in cervical intra-epithelial neoplasia without concomitant cervical carcinoma. Pathobiology66:306-310, 1998
15.
15. Chung TK, Cheung TH, Lo WK, Yu MY, Hampton GM, Wong HK, Wong YF. Loss of heterozygosity at the short arm of chromosome 3 in microdissected cervical intreaepithelial neoplasia. Cancer Lett154:189-194, 2000
16.
16. Kohno T, Takayama H, Hamaguchi M, Takano H, Yamaguchi N, Tsuda H, Hirohashi S, Vissing H, Shimizu M, Oshimura M. Deletion mapping of chromosome 3p in human uterine cervical cancer. Oncogene8:1825-1832, 1993
17.
17. Kersemaekers AM, van de Vijver MJ, Kenter GG, Fleuren GJ. Genetic alterations during the progression of squamous cell carcinomas of the uterine cervix. Genes Chromosomes Cancer26:346-354, 1999
18.
18. Kersemaekers AM, Hermans J, Fleuren GJ, van de Vijver MJ. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix. Br J Cancer77:192-200, 1998
19.
19. Mullokandov MR, Kholodilov NG, Atkin NB, Burk RD, Johnson AB, Klinger HP. Genomic alterations in cervical carcinoma: Losses of chromosome heterozygosity and human papilloma virus tumor status. Cancer Res56:197-205, 1996
20.
20. Luft F, Gebert J, Schneider A, Melsheimer P, von Knebel DM. Frequent allelic imbalance of tumor suppressor gene loci in cervical dysplasia. Int J Gynecol Pathol18:374-380, 1999
21.
21. Carey TE, Frank CJ, Raval JR, Jones JW, McClatchey KD, Beals TF, Worsham MJ, Van Dyke DL. Identifying genetic changes associated with tumor progression in squamous cell carcinoma. Acta Otolaryngol529(Suppl):229-232, 1997
22.
22. Mitra AB, Murty VV, Li RG, Pratap M, Luthra UK, Chaganti RS. Allelotype analysis of cervical carcinoma. Cancer Res54:4481-4487, 1994
23.
23. Larson AA, Kern S, Sommers RL, Yokota J, Cavenee WK, Hampton GM. Analysis of replication error (RER+) phenotypes in cervical carcinoma. Cancer Res56:1426-1431, 1996
24.
24. Hu X, Guo Z, Pang T, Li Q, Afink G, Ponten J. Immunohistochemical and DNA sequencing analysis on human mismatch repair gene MLH1 in cervical squamous cell carcinoma with LOH of this gene. Anticancer Res20:171-175, 2000
25.
25. Nishimura M, Furumoto H, Kato T, Kamada M, Aono T. Microsatellite instability is a late event in the carcinogenesis of uterine cervical cancer. Gynecol Oncol79:201-206, 2000
